Envoy Medical, Inc. (COCH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 35K 70K 105K Q3 '22: 57K Q4 '22: 20K Q1 '23: 78K Q2 '23: 63K Q3 '23: 80K Q4 '23: 95K Q1 '24: 59K Q2 '24: 68K Q3 '24: 56K Q4 '24: 42K Q1 '25: 46K Q2 '25: 78K Q3 '25: 42K Q4 '25: 75K Q1 '26: 39K Q2 '26: 51K Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

-300K -200K -100K 0 100K 200K 300K Q3 '22: -49K Q4 '22: -131K Q1 '23: -97K Q2 '23: -99K Q3 '23: -109K Q4 '23: -139K Q1 '24: -94K Q2 '24: -177K Q3 '24: -131K Q4 '24: -115K Q1 '25: -180K Q2 '25: -156K Q3 '25: -161K Q4 '25: -136K Q1 '26: -274K Q2 '26: -227K Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '21: -966.3K Q2 '21: -1.1M Q3 '21: -3M Q4 '21: -963.9K Q1 '22: -1.5M Q2 '22: -901.4K Q3 '22: -1.8M Q4 '22: -2.9M Q1 '23: -3.8M Q2 '23: -4.5M Q3 '23: -3.4M Q4 '23: -6.7M Q1 '24: -4.9M Q2 '24: -4.9M Q3 '24: -5M Q4 '24: -4.5M Q1 '25: -5.1M Q2 '25: -5.1M Q3 '25: -5.7M Q4 '25: -6.4M Q1 '26: -6M Q2 '26: -5.6M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q1 '21: -1.5M Q2 '21: 371.1K Q3 '21: 5.6M Q4 '21: -4.7M Q1 '22: -1.9M Q2 '22: -1.2M Q3 '22: -1.3M Q4 '22: 2.3M Q1 '23: -13.3M Q2 '23: -13.3M Q3 '23: 1.6M Q4 '23: -4.9M Q1 '24: -6.3M Q2 '24: -3.9M Q3 '24: -6M Q4 '24: -4.6M Q1 '25: -5M Q2 '25: -5.7M Q3 '25: -6.5M Q4 '25: -6.6M Q1 '26: -4.4M Q2 '26: -6M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 150K 300K 450K Q3 '22: 106K Q4 '22: 151K Q1 '23: 175K Q2 '23: 162K Q3 '23: 189K Q4 '23: 234K Q1 '24: 153K Q2 '24: 245K Q3 '24: 187K Q4 '24: 157K Q1 '25: 226K Q2 '25: 234K Q3 '25: 203K Q4 '25: 211K Q1 '26: 313K Q2 '26: 278K Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q1 '21: -1.2M Q2 '21: -405.3K Q3 '21: -701.4K Q4 '21: -885.2K Q1 '22: -772.7K Q2 '22: -400.2K Q3 '22: -5.3M Q4 '22: -2.4M Q1 '23: -3M Q2 '23: -4M Q3 '23: 1.1M Q4 '23: -11.1M Q1 '24: -5.6M Q2 '24: -4.6M Q3 '24: -2.6M Q4 '24: -5.1M Q1 '25: -3.7M Q2 '25: -4.5M Q3 '25: -4.3M Q4 '25: -5.7M Q1 '26: -6.1M Q2 '26: -5.5M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q4 '22: -2.4M Q1 '23: -3.1M Q2 '23: -4M Q3 '23: 1M Q4 '23: -11.2M Q1 '24: -5.7M Q3 '24: -3.8M Q1 '25: -3.7M Q2 '25: -4.5M Q3 '25: -4.3M Q4 '25: -5.9M Q4 '22 Q2 '23 Q4 '23 Q3 '24 Q2 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q3 '22: 10.1M Q1 '23: 10.1M Q2 '23: 10.1M Q3 '23: 11.2M Q1 '24: 18.6M Q2 '24: 18.6M Q3 '24: 18.6M Q1 '25: 21.3M Q2 '25: 21.4M Q3 '25: 21.9M Q1 '26: 68.9M Q2 '26: 104M Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '23: -3.88 Q3 '23: -3.62 Q4 '23: -2.57 Q1 '24: -1.67 Q2 '24: -0.65 Q3 '24: -1.17 Q4 '24: -1.49 Q1 '25: -1.37 Q2 '25: -1.40 Q3 '25: -1.36 Q4 '25: -1.22 Q1 '26: -1.01 Q2 '26: -0.76 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.